Literature DB >> 25666645

NAFLD. Accurate quantification of hepatic fat--is it important?

Leon A Adams1.   

Abstract

New ultrasonography and MRI techniques offer the promise of accessible and accurate quantification of hepatic steatosis. Application of these techniques to help define the natural history and severity of NAFLD is required before we can determine their clinical utility.

Entities:  

Mesh：

Year:  2015        PMID： 25666645     DOI： 10.1038/nrgastro.2015.23

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

Review 3.  Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.

Authors:  Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

4.  Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

Authors:  Jennifer E Lambert; Maria A Ramos-Roman; Jeffrey D Browning; Elizabeth J Parks
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

5.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.

Authors:  Steven C Lin; Elhamy Heba; Tanya Wolfson; Brandon Ang; Anthony Gamst; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Claude B Sirlin; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-03       Impact factor: 11.382

6.  Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Elizabeth M Brunt; David E Kleiner; Kris V Kowdley; Naga Chalasani; Joel E Lavine; Vlad Ratziu; Arthur McCullough
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

7.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.

Authors:  Kevin M Korenblat; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

8.  Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.

Authors:  Mazen Noureddin; Jessica Lam; Michael R Peterson; Michael Middleton; Gavin Hamilton; Thuy-Anh Le; Ricki Bettencourt; Chris Changchien; David A Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

9.  Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).

Authors:  Rohit Loomba; Claude B Sirlin; Brandon Ang; Ricki Bettencourt; Rashmi Jain; Joanie Salotti; Linda Soaft; Jonathan Hooker; Yuko Kono; Archana Bhatt; Laura Hernandez; Phirum Nguyen; Mazen Noureddin; William Haufe; Catherine Hooker; Meng Yin; Richard Ehman; Grace Y Lin; Mark A Valasek; David A Brenner; Lisa Richards
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

10.  Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.

Authors:  Rohit Loomba; Tanya Wolfson; Brandon Ang; Jonathan Hooker; Cynthia Behling; Michael Peterson; Mark Valasek; Grace Lin; David Brenner; Anthony Gamst; Richard Ehman; Claude Sirlin
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425
  10 in total
  3 in total

Review 1.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

Review 2.  Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giovanni Guaraldi; Fabio Nascimbeni; Dante Romagnoli; Stefano Zona; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

3.  Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.

Authors:  Dong Hyun Sinn; Soo Jin Cho; Geum-Youn Gwak; Juhee Cho; Seonhye Gu; Donghyeong Seong; Danbee Kang; Hyunkyoung Kim; Byoung-Kee Yi; Seung Woon Paik
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.